nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—TACR1—SIDS Susceptibility Pathways—C4B—systemic lupus erythematosus	0.0184	0.0189	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—C4A—systemic lupus erythematosus	0.0184	0.0189	CbGpPWpGaD
Vapreotide—SSTR5—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.0156	0.016	CbGpPWpGaD
Vapreotide—SSTR2—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.0144	0.0147	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—FCGR2A—systemic lupus erythematosus	0.014	0.0143	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—P2RY12—systemic lupus erythematosus	0.0134	0.0137	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.0125	0.0128	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—P2RY12—systemic lupus erythematosus	0.0124	0.0127	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	0.0123	0.0125	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Other—CCR5—systemic lupus erythematosus	0.0122	0.0125	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—GADD45A—systemic lupus erythematosus	0.0119	0.0121	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.0115	0.0118	CbGpPWpGaD
Vapreotide—TACR1—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.0113	0.0116	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.0107	0.011	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.0107	0.0109	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.00988	0.0101	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.00985	0.0101	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	0.00965	0.00988	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CXCL12—systemic lupus erythematosus	0.00903	0.00925	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	0.00877	0.00898	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL4—systemic lupus erythematosus	0.0084	0.0086	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CXCL12—systemic lupus erythematosus	0.00834	0.00854	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.00813	0.00832	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	0.00811	0.00831	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CXCL12—systemic lupus erythematosus	0.00778	0.00797	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.00776	0.00794	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.0075	0.00768	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.00735	0.00753	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.00734	0.00752	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.00718	0.00736	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.00717	0.00734	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TLR4—systemic lupus erythematosus	0.00696	0.00712	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	0.0069	0.00707	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.00677	0.00694	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.00663	0.00679	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.00662	0.00678	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.00657	0.00673	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	0.00639	0.00654	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.0063	0.00645	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CCR5—systemic lupus erythematosus	0.00619	0.00634	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—C3—systemic lupus erythematosus	0.00605	0.0062	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CCL2—systemic lupus erythematosus	0.00597	0.00611	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.00591	0.00605	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.00581	0.00595	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.00575	0.00588	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CCR5—systemic lupus erythematosus	0.00571	0.00585	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.00561	0.00575	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—C3—systemic lupus erythematosus	0.00558	0.00572	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.00547	0.0056	CbGpPWpGaD
Vapreotide—SSTR2—kidney—systemic lupus erythematosus	0.00534	0.228	CbGeAlD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCR5—systemic lupus erythematosus	0.00533	0.00546	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.0053	0.00543	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.00522	0.00534	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—C3—systemic lupus erythematosus	0.00521	0.00534	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.00518	0.0053	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.0051	0.00522	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IFNG—systemic lupus erythematosus	0.00508	0.0052	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.00505	0.00517	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.00492	0.00504	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—PTGS2—systemic lupus erythematosus	0.00487	0.00498	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.00481	0.00493	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.00463	0.00475	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	0.00461	0.00472	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.00459	0.0047	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—F2—systemic lupus erythematosus	0.00458	0.00469	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.00454	0.00465	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL2—systemic lupus erythematosus	0.00451	0.00462	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.00444	0.00455	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—MMP9—systemic lupus erythematosus	0.00427	0.00437	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.00424	0.00434	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.00422	0.00433	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.00417	0.00427	CbGpPWpGaD
Vapreotide—TACR1—connective tissue—systemic lupus erythematosus	0.00417	0.178	CbGeAlD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.00414	0.00424	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	0.00411	0.00421	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CCL2—systemic lupus erythematosus	0.00408	0.00418	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.00397	0.00407	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.0039	0.00399	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	0.00389	0.00399	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.00385	0.00394	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.00376	0.00386	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.00375	0.00384	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—C3—systemic lupus erythematosus	0.00366	0.00375	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.00358	0.00366	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	0.00352	0.0036	CbGpPWpGaD
Vapreotide—SSTR2—nervous system—systemic lupus erythematosus	0.0035	0.149	CbGeAlD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.0035	0.00358	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.00347	0.00356	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.00346	0.00354	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—C3—systemic lupus erythematosus	0.00338	0.00346	CbGpPWpGaD
Vapreotide—SSTR2—central nervous system—systemic lupus erythematosus	0.00337	0.144	CbGeAlD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	0.00335	0.00343	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.00334	0.00342	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	0.00334	0.00342	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TNF—systemic lupus erythematosus	0.00329	0.00336	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	0.00324	0.00331	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—F2—systemic lupus erythematosus	0.00322	0.00329	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.00309	0.00317	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.00307	0.00314	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	0.00307	0.00314	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.00303	0.0031	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—F2—systemic lupus erythematosus	0.00297	0.00304	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.00288	0.00295	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.00287	0.00294	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.00285	0.00292	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.00281	0.00287	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.00274	0.0028	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.00272	0.00279	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	0.00269	0.00276	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—C3—systemic lupus erythematosus	0.00266	0.00273	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.00266	0.00272	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—IL6—systemic lupus erythematosus	0.00265	0.00271	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.00265	0.00271	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	0.00263	0.00269	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.00262	0.00268	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.00259	0.00265	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TLR9—systemic lupus erythematosus	0.00254	0.00261	CbGpPWpGaD
Vapreotide—TACR1—lung—systemic lupus erythematosus	0.00251	0.107	CbGeAlD
Vapreotide—SSTR5—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.00246	0.00252	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.00242	0.00247	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TLR9—systemic lupus erythematosus	0.00235	0.0024	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—F2—systemic lupus erythematosus	0.00234	0.00239	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.00233	0.00238	CbGpPWpGaD
Vapreotide—TACR1—nervous system—systemic lupus erythematosus	0.00233	0.0992	CbGeAlD
Vapreotide—SSTR2—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.00227	0.00233	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CSK—systemic lupus erythematosus	0.00227	0.00232	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.00225	0.0023	CbGpPWpGaD
Vapreotide—TACR1—central nervous system—systemic lupus erythematosus	0.00224	0.0955	CbGeAlD
Vapreotide—SSTR5—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.00224	0.00229	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.00215	0.0022	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	0.00212	0.00217	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.00212	0.00217	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.00209	0.00214	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CSK—systemic lupus erythematosus	0.00209	0.00214	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.00209	0.00214	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.00208	0.00213	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NCF2—systemic lupus erythematosus	0.00207	0.00212	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—C3—systemic lupus erythematosus	0.00207	0.00212	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.00206	0.00211	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—LYN—systemic lupus erythematosus	0.00206	0.00211	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.00204	0.00209	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.00203	0.00208	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.00202	0.00207	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.00196	0.002	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.00193	0.00197	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.00192	0.00197	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NCF2—systemic lupus erythematosus	0.00191	0.00196	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—C3—systemic lupus erythematosus	0.00191	0.00196	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.0019	0.00195	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—LYN—systemic lupus erythematosus	0.0019	0.00195	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.0019	0.00194	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—C3—systemic lupus erythematosus	0.00188	0.00193	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.00187	0.00192	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.00187	0.00191	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TLR9—systemic lupus erythematosus	0.00185	0.00189	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—F2—systemic lupus erythematosus	0.00182	0.00186	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.00179	0.00183	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.00178	0.00182	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.00175	0.00179	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—C3—systemic lupus erythematosus	0.00174	0.00178	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	0.00169	0.00173	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—F2—systemic lupus erythematosus	0.00168	0.00172	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.00166	0.0017	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—F2—systemic lupus erythematosus	0.00165	0.00169	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CSK—systemic lupus erythematosus	0.00165	0.00169	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	0.00164	0.00168	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JUNB—systemic lupus erythematosus	0.00163	0.00167	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—JAK1—systemic lupus erythematosus	0.00162	0.00166	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.00155	0.00158	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CCR5—systemic lupus erythematosus	0.00154	0.00158	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.00153	0.00157	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—F2—systemic lupus erythematosus	0.00152	0.00156	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	0.00152	0.00155	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NCF2—systemic lupus erythematosus	0.00151	0.00154	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—C3—systemic lupus erythematosus	0.0015	0.00154	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JUNB—systemic lupus erythematosus	0.0015	0.00154	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PRL—systemic lupus erythematosus	0.0015	0.00154	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—LYN—systemic lupus erythematosus	0.0015	0.00153	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—JAK1—systemic lupus erythematosus	0.00148	0.00151	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.00147	0.00151	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—SH2B3—systemic lupus erythematosus	0.00147	0.0015	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.00143	0.00146	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCR5—systemic lupus erythematosus	0.0014	0.00143	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PRL—systemic lupus erythematosus	0.00138	0.00142	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL2RA—systemic lupus erythematosus	0.00138	0.00141	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—C3—systemic lupus erythematosus	0.00137	0.0014	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.00136	0.00139	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.00134	0.00137	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—F2—systemic lupus erythematosus	0.00132	0.00135	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.00123	0.00126	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.00122	0.00125	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL12—systemic lupus erythematosus	0.0012	0.00123	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—JAK1—systemic lupus erythematosus	0.0012	0.00123	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—F2—systemic lupus erythematosus	0.0012	0.00123	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JUNB—systemic lupus erythematosus	0.00118	0.00121	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCR5—systemic lupus erythematosus	0.00114	0.00116	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.00113	0.00116	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RASGRP1—systemic lupus erythematosus	0.00112	0.00115	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.00112	0.00115	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL2—systemic lupus erythematosus	0.00111	0.00114	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—C3—systemic lupus erythematosus	0.00111	0.00114	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—JAK1—systemic lupus erythematosus	0.00111	0.00113	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PRL—systemic lupus erythematosus	0.00109	0.00112	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CCL2—systemic lupus erythematosus	0.00107	0.00109	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCR5—systemic lupus erythematosus	0.00105	0.00107	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.00103	0.00106	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL2—systemic lupus erythematosus	0.00103	0.00105	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—C3—systemic lupus erythematosus	0.00102	0.00105	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—F2—systemic lupus erythematosus	0.000975	0.000998	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—TYK2—systemic lupus erythematosus	0.000971	0.000994	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CD80—systemic lupus erythematosus	0.000935	0.000957	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—F2—systemic lupus erythematosus	0.0009	0.000921	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—IL2—systemic lupus erythematosus	0.000889	0.000911	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—JAK1—systemic lupus erythematosus	0.000871	0.000892	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CCL2—systemic lupus erythematosus	0.000869	0.00089	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CD80—systemic lupus erythematosus	0.000863	0.000883	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCR5—systemic lupus erythematosus	0.000826	0.000846	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL2RA—systemic lupus erythematosus	0.000814	0.000833	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL2—systemic lupus erythematosus	0.000808	0.000827	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—C3—systemic lupus erythematosus	0.000807	0.000826	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CCL2—systemic lupus erythematosus	0.000802	0.000821	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TYK2—systemic lupus erythematosus	0.000789	0.000808	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—NOS3—systemic lupus erythematosus	0.000775	0.000793	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TYK2—systemic lupus erythematosus	0.000728	0.000746	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—NOS3—systemic lupus erythematosus	0.000715	0.000732	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—F2—systemic lupus erythematosus	0.000708	0.000725	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CD80—systemic lupus erythematosus	0.000679	0.000696	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	0.000671	0.000687	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL2—systemic lupus erythematosus	0.000657	0.000672	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—IL6—systemic lupus erythematosus	0.000653	0.000669	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CCL2—systemic lupus erythematosus	0.000631	0.000647	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—MMP9—systemic lupus erythematosus	0.000621	0.000636	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	0.000619	0.000634	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	0.000619	0.000634	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL2—systemic lupus erythematosus	0.000606	0.000621	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—IL6—systemic lupus erythematosus	0.000603	0.000617	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EP300—systemic lupus erythematosus	0.000589	0.000603	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—MMP9—systemic lupus erythematosus	0.000574	0.000587	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TYK2—systemic lupus erythematosus	0.000573	0.000587	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	0.000571	0.000585	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—NOS3—systemic lupus erythematosus	0.000563	0.000576	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—VEGFA—systemic lupus erythematosus	0.000558	0.000571	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EP300—systemic lupus erythematosus	0.000544	0.000557	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—VEGFA—systemic lupus erythematosus	0.000515	0.000527	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—TGFB1—systemic lupus erythematosus	0.000512	0.000525	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	0.000488	0.000499	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL2—systemic lupus erythematosus	0.000477	0.000489	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—IL6—systemic lupus erythematosus	0.000475	0.000486	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—TGFB1—systemic lupus erythematosus	0.000473	0.000484	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—MMP9—systemic lupus erythematosus	0.000452	0.000462	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	0.00045	0.000461	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EP300—systemic lupus erythematosus	0.000428	0.000438	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—VEGFA—systemic lupus erythematosus	0.000405	0.000415	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—IL6—systemic lupus erythematosus	0.000386	0.000395	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—TGFB1—systemic lupus erythematosus	0.000372	0.000381	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—IL6—systemic lupus erythematosus	0.000356	0.000365	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—IL6—systemic lupus erythematosus	0.00028	0.000287	CbGpPWpGaD
